Bain, Cinven win €4.1bn Stada deal as public-to-privates reappear
Bain Capital and Cinven have agreed to buy Stada, the German generic pharmaceuticals firm, for €4.1bn, in what Dealogic shows is the biggest public-to-private buyout of a European company for four years.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: